Investors Cheering as Insiders Bet Big on Greenwich LifeSciences and More

Avatar photo

The closing bell on U.S. stock markets may have rung a mostly somber note last Friday, but astute investors had reason to cheer with a series of insider trades lighting up the financial landscape.

Insiders betting big indicates not just faith in the company’s future but also a belief the stock is undervalued. It’s akin to spotting a rare gem in a sea of gravel – a chance to ride a bullish wave. While insider moves aren’t the single metric for investment decisions, they serve as a sturdy vote of confidence.

Let’s delve into some recent noteworthy insider trades that are stirring up the market waters. For more, venture into Benzinga’s insider transactions platform.

Insider Insight: Harrow

  • The Lowdown: Harrow, Inc. HROW saw Opaleye Management Inc., a 10% owner, snagging 50,600 shares at an average price of $9.65. The total price tag for this stake? A cool $488,290.
  • Under the Microscope: March 19 witnessed Harrow unveiling fourth-quarter financials that failed to hit the mark.
  • What’s Harrow About: Harrow Inc plays in the eyecare pharmaceutical domain, dabbling in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market.

Greenwich LifeSciences Gains Momentum

  • The Skinny: Greenwich LifeSciences, Inc. GLSI witnessed CEO and CFO Snehal Patel jumping on board, acquiring 1,500 shares at $17.68 on average. This move set back Patel around $26,520.
  • The Buzz: March 12 marked Greenwich LifeSciences kicking off clinical trials in Europe, partnering with GEICAM in Spain.
  • What’s in the Pipeline: Greenwich LifeSciences Inc is knee-deep in clinical-stage biopharmaceutical pursuits, centering on GP2 – an immunotherapy aimed at stymying breast cancer recurrences in surgery veterans.

Beep beep! Don’t miss out on our latest premarket insights here

Real Estate Rumble with BRT Apartments

  • The Revelation: BRT Apartments Corp. BRT saw Gould Investors L P, a 10% stakeholder, snapping up 3,471 shares at an average cost of $16.26. The price tag for this action? A hefty $56,450.
  • The Lowdown: March 12 painted a gloomy picture for BRT Apartments with less-than-upbeat quarterly sales figures.
  • What’s BRT About: BRT Apartments Corp stands tall as a real estate investment trust player, honing its focus on the ownership, operation, and development of multifamily properties.

 

Catch this: Dive into the top 5 consumer stocks that might take a nosedive this month

Simplifying the market for savvy investing

Trade smarter with insights, alerts on analyst ratings, free reports, and breaking news that impacts your stock interests.


The free Daily Market Overview 250k traders and investors are reading

Read Now